Concepedia

Susanna Jacobus

SJ

Statistics

Publications

43

Citations

5K

H-Index

30

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Mayo Clinic in Arizona

Harvard University

University of Wisconsin–Madison

Hackensack University Medical Center

Susanna Jacobus is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2022

43

Publications

43

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

S. Vincent Rajkumar, Susanna Jacobus, Natalie S. Callander et al. · The Lancet Oncology · 2009 · 930 citations · Full text

, , +8

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

Hajime Uno, Brian Claggett, Lü Tian et al. · Journal of Clinical Oncology · 2014 · 721 citations · Full text

, , +15

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson, Susanna Jacobus, Edie Weller et al. · New England Journal of Medicine · 2022 · 428 citations · Full text

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

Sagar Lonial, Susanna Jacobus, Rafaël Fonseca et al. · Journal of Clinical Oncology · 2019 · 295 citations · Full text

Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib

Nikhil Wagle, Brian C. Grabiner, Eliezer M. Van Allen et al. · Cancer Discovery · 2014 · 277 citations · Full text

, , +15

1–5 of 43